N/A N=149 Family-Centered Cesarean Delivery
Patient Satisfaction · Earlier Family Bond Initiation · Maternal and Neonatal Outcomes
Primary: 11-item Patient Satisfaction Questionnaire — 4.6; 4.4; 4.6; 4.3 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=79 Improving Cesarean Section Experience Through Hypnotherapy
Cesarean Section · Pain · Anxiety
Primary: Wellbeing Measured Using a Comfort Scale — 6.7; 8.0 units on a scale
N/A N=541 Cesarean Section Via Enhanced Recovery
Cesarean Section
Primary: Opioid Consumption — 60.34; 104.33 oral morphine equivalents (mg) — p=< 0.001
N/A N=69 High Pain Intervention in Cesarean Sections
Other Chronic Postoperative Pain
Primary: Severity of Acute Pain — 46; 31 mm — p=0.05
N/A N=1,485 Effect of a Patient-Centered Decision App on TOLAC
Pregnancy · Repeat Cesarean Section · Vaginal Births After Cesarean
Primary: Number of Participants Who Underwent a Trial of Labor After Cesarean (TOLAC) Delivery — 315; 338 Participants
N/A N=92 The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions
Post-operative Complications · Surgical Site Infection · Surgical Wound Infection
Primary: Incidence of Postoperative Surgical Site Occurrences (SSOs) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery. — 7; 2 participants
Phase 4 N=753 Seprafilm® Adhesion Barrier and Cesarean Delivery
Adhesions · Cesarean Section · Delivery, Obstetric
Primary: Incidence of Adhesions — 75.6; 75.9 percentage of patients with adhesions
N/A N=140 Dural Puncture Epidural Versus Epidural Anesthesia for Cesarean Delivery
Pain Levels
Primary: Onset Time of Surgical Anesthesia — 422; 655 seconds
N/A N=96 Scalpel vs Diathermy in Repeat Cesarean Delivery
Complications; Cesarean Section
Primary: Incision Time . — 271.5; 188.17 Seconds — p=<0.001
Phase 4 N=90 Copper Intrauterine Device (IUD) Insertion at Cesarean Delivery
Intrauterine Device Expulsion
Primary: Number of Participants With Expulsion of IUD — 54; 0 Participants
N/A N=190 Opioid Prescribing After Cesarean Delivery
Surgery · Opioid Use
Primary: Unused Opioids — 5; 10 oxycodone 5mg tablets
Phase 4 N=23 Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery
Cesarean Delivery · Wound Infection · Obesity
Primary: Cefazolin Levels — 18.36; 40.11; 21.73; 34.89 mcg/mL — p=<0.01
N/A N=746 Cesarean Trial of Staples vs. Sutures
Cesarean Section · Wound Complications · Patient Satisfaction
Primary: Number of Participants With Wound Complications — 18; 40; 9; 14 Participants
N/A N=22 Music vs. No Music During Cesarean Delivery on Patient Satisfaction
Patient Satisfaction
Primary: Patient Satisfaction — 120; 116 units on a scale
Phase 4 N=20 The Invia Motion at Cesarean Study
Negative Pressure Wound Therapy · Cesarean Section; Infection
Primary: Pain Scores: Discharge Time Frame — 2.5 score on a scale
N/A N=78 Randomized Control Trial of Second Stage of Labor
Labor Complications
Primary: Number of Patients Delivered by Cesarean — 16; 8 Participants
N/A N=40 Opportunistic Salpingectomy for Permanent Sterilization at the Time of Cesarean Delivery
Contraception
Primary: Mean Difference Between Pre and Postoperative Hemoglobin (g/dl) — 1.4; 1.8 g/dL — p=0.08
N/A N=168 Short Term Comparison of Two Different Techniques of Uterine Cesarean Incision Closure
Cesarean Section Complications
Primary: Cesarean Scar Defect in the Uterine Incisional Line — 12; 39 participants — p=0.0001
N/A N=1,404 Comparison of Surgical Skin Preps During Cesarean Deliveries
Surgical Site Infection Following Cesarean Delivery
Primary: Cesarean Surgical Site Infection — 18; 21; 21; 15 Participants
N/A N=112 Immediate Postplacental Insertion of IUDs at Time of Cesarean Delivery: A Randomized Clinical Trial
Intrauterine Devices · Cesarean Section
Primary: IUD Use — 32; 40 participants
N/A N=1,274 Timing of Planned Caesarean Section and Morbidity of the Newborn
Respiratory Disorders · Intensive Care, Neonatal
Primary: Neonatal Admission After Elective Caesarean Section — 88; 76 participants — p=0.31
N/A N=70 Impact of Skin to Skin Contact on Maternal Satisfaction, Pain Scores, and Narcotic Usage After Cesarean Delivery
Skin to Skin Contact in Cesarean Deliveries
Primary: Maternal Evoked Pain Scores — 43.55 units on a scale
N/A N=110 Negative Pressure Wound Therapy After Cesarean Delivery
Major Puerperal Infection, Postpartum · Wound Complications · Wound Seroma
Primary: Wound Complication Rate — 3; 1; 3; 6 participants
N/A N=400 Timing of Antibiotic Prophylaxis for Cesarean Deliveries
Infection
Primary: Endometritis and Wound Infection — 6; 4 patients infected
N/A N=240 Glove Perforation When Using Blunt Verses Sharp Needles in Cesarean Delivery
Cesarean Delivery · Glove Perforation
Primary: Surgical Glove Perforation. — 30; 30 Cases with a glove puncture
N/A N=168 Long Term Comparison of Two Different Techniques of Uterine Cesarean Incision Closure
Cesarean Section; Complications · Placenta Previa · Placenta Accreta
Primary: Placenta Previa — 18; 17; 0; 3 Participants
N/A N=657 Prospective Study on Cesarean Wound Outcomes
Surgical Site Infection · Cosmetic Appearance of Cesarean Scar · Post Operative Pain
Primary: Percentage of Patients Who Develop a Surgical Site Infection — 14; 15 Participants — p=<0.05
Phase 4 N=120 Multimodal Pain Management for Cesarean Delivery
Pain
Primary: Total Opioid Intake in Morphine Milligram Equivalents in the First 48 Hours After Cesarean Delivery (CD) — 42; 49.5 morphine milligram equivalents
Phase 2 N=130 Enemas Before Elective Cesarean Section
Complications After Cesarean Section
Primary: Number of Participants With Bowel Sounds — 23; 31 participants — p=0.15
Phase 4 N=49 Dexamethasone for Post-cesarean Delivery Pain
Pain, Postoperative · Postoperative Nausea and Vomiting
Primary: Morphine Consumption at 24 Hours Post-op — 15; 13.75 milligram — p=0.740